Table 1

Clinical and laboratory data of the patient population (M ± SD;percent)



normal values

Patient, n°
269

Sex, (M/F)
150/119

Age, years
65,8 ± 11,9

Weight, Kg
70,8 ± 11,9

Creatinine, mg/dl
1,7 ± 1
(0,6–1,2)
Cr. Clearance, ml/min
54,8 ± 30,2
(90–120)
Urea, mg/dl
61,2 ± 33,2
(10–45)
Uric acid, mg/dl
6,5 ± 1,8
(3–7)
Sodium, mEq/L
142 ± 4,3
(136–145)
Potassium, mEq/L
4,6 ± 0,5
(3,6–5)
Cholesterol, mg/dl
243 ± 53
(150–220)
HDL cholesterol, mg/dl
49 ± 13,6
(>45)
Triglycerides, mg/dl
162 ± 83
(50–200)
Urinary protein, mg/24 h
654 ± 1103
(<150)
Systolic BP, mmHg
170 ± 25
(<140)
Diastolic BP, mmHg
96 ± 14
(<90)
Duration of hypertension, years
7,5 ± 6



%
Arterial hypertension
238
88,5
Familiar hypertension
113
42,0
Smoking
89
33,0
Diabetes mellitus
42
15,6
Hypertensive retinopathy (stage III and IV) (163/269)
4
2,5
Interventricular septum (154/269)
121
78,5
Stenosis of epiaortic arteries (111/269)
60
54,0
Stenosis of iliofemoral arteries (52/269)
33
63,5
Renal dimensions asymmetry (>11 mm)
135
50,2

Coen et al. BMC Nephrology 2003 4:2   doi:10.1186/1471-2369-4-2